MENDICINO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 55
EU - Europa 50
AS - Asia 30
OC - Oceania 2
Totale 137
Nazione #
US - Stati Uniti d'America 54
IT - Italia 36
SG - Singapore 26
GB - Regno Unito 7
DE - Germania 2
FI - Finlandia 2
IN - India 2
NZ - Nuova Zelanda 2
PL - Polonia 2
CA - Canada 1
HK - Hong Kong 1
IR - Iran 1
SE - Svezia 1
Totale 137
Città #
Singapore 13
Chandler 8
Santa Clara 7
Ashburn 5
Chicago 5
Catanzaro 4
London 4
Milan 4
Boardman 3
Pistoia 3
Auckland 2
Chennai 2
Helsinki 2
Lawrence 2
Princeton 2
Rome 2
Rozzano 2
Acri 1
Bowmanville 1
Des Moines 1
Hanover 1
Munich 1
Turin 1
Totale 76
Nome #
COVID-19: high-JAKing of the inflammatory “flight” by ruxolitinib to avoid the cytokine storm 62
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 19
Belantamab mafodotin in multiple myeloma 14
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 14
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 14
Elotuzumab in multiple myeloma 13
Isatuximab in multiple myeloma 11
Totale 147
Categoria #
all - tutte 1.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 10 9 0 2 0 5 0
2021/202215 0 2 0 1 0 7 1 1 0 0 3 0
2022/202326 5 2 1 1 1 2 4 3 3 2 2 0
2023/202441 5 8 4 8 3 9 0 0 0 0 1 3
2024/202539 7 2 1 2 4 10 0 0 12 1 0 0
Totale 147